We
have linked a new type of stable nitroxyl radical, polynitroxylated
albumin (PNA), to cadmium telluride (CdTe) quantum dots (QDs) to form
CdTe–PNA nanocomposites, in which PNA can effectively quench
QDs’ photoluminescence (PL). We have demonstrated that CdTe–PNA
can be used for glutathione detection by measuring the PL recovery.
Utilizing the albumin as a linker between QDs and the radicals, the
water-soluble CdTe–PNA probe exhibits good biocompatibility
and luminescent properties. Using static PL, lifetime, and electron
paramagnetic resonance spectroscopy measurements, we have proposed
a CdTe PL quenching mechanism based on quencher PNA. The results indicate
that QDs reduce nitroxides on PNA to hydroxylamines, and dynamic quenching
is the predominant process. The optimized formula has a 2200:1 molar
ratio of nitroxide to QDs, which gives a lower limit of glutathione
detection of 20 nM and a linearity range of 5–60 μM (R
2 = 0.99). In addition, cytotoxicity testing
shows that introducing albumin can effectively reduce the cytotoxicity
from both CdTe QDs and nitroxide radicals. Because PNA has 30 nitroxides
per albumin, the detection advantages of CdTe–PNA can be attributed
to the high local concentration of nitroxides and a redox cycling
process of electron transfer between QDs and polynitroxides. The new
CdTe–PNA PL nanocomposite has broadened application perspectives
of QDs in the diagnosis of cancers or other diseases when using glutathione
as a biomarker.